Financhill
Back

Amedisys Quote, Financials, Valuation and Earnings

Amedisys Price Quote

$84.56
+0.07 (+0.93%)
(Updated: December 21, 2024 at 5:14 AM ET)

Amedisys Key Stats

Sell
47
Amedisys (AMED) is a Sell

Day range:
$82.15 - $84.87
52-week range:
$82.15 - $98.95
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.20
P/B ratio:
2.41%

Volume:
2.3M
Avg. volume:
720.6K
1-year change:
-11.09%
Market cap:
$2.8B
Revenue:
$2.2B
EPS:
$2.52

How Much Does Amedisys Make?

Data Unavailable

Is Amedisys Growing As A Company?

Data Unavailable

Amedisys Stock Price Performance

  • Did Amedisys Stock Go Up Last Month?
    Amedisys share price went down by -6.12% last month
  • Did AMED's Share Price Rise Over The Last Year?
    AMED share price fell by -11.09% over the past 1 year

What Is Amedisys 52-Week High & Low?

  • What Is Amedisys’s 52-Week High Share Price?
    Amedisys has traded as high as $98.95 over the past 52 weeks
  • What Is Amedisys’s 52-Week Low Share Price?
    Amedisys has traded as low as $82.15 over the past 52 weeks

Amedisys Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Amedisys?

Data Unavailable

Is Amedisys Cash Flow Positive?

Data Unavailable

Amedisys Return On Invested Capital

Data Unavailable

Amedisys Earnings Date & Stock Price

  • What Is Amedisys's Stock Price Today?
    A single share of AMED can be purchased today for 84.49
  • What Is Amedisys’s Stock Symbol?
    Amedisys trades on the nasdaq under the ticker symbol: AMED
  • When Is Amedisys’s Next Earnings Date?
    The next quarterly earnings date for Amedisys is scheduled on February 21, 2025
  • When Is AMED's next ex-dividend date?
    Amedisys's next ex-dividend date is December 22, 2024
  • How To Buy Amedisys Stock?
    You can buy Amedisys shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Amedisys Competitors

  • Who Are Amedisys's Competitors?
    Below is a list of companies who compete with Amedisys or are related in some way:
    • Addus HomeCare Corp (ADUS)
    • Chemed Corp (CHE)
    • Option Care Health Inc (OPCH)
    • OptimizeRx Corp (OPRX)
    • Regional Health Properties Inc (RHE)

Amedisys Dividend Yield

Data Unavailable

Amedisys Analyst Estimates

YoY Growth Past Surprise
EPS: -35.44% -14.33%
Revenue: 5.65% -0.19%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable